Table 4.

Factors associated with the occurrence of CAPA (univariate and multivariate analysis)

	No CAPA (n = 415)	CAPA (n = 22)	p-value	Multivariate OR (95%IC), p-value
MV, days, median (Q1;Q3)	9 (5;19)	21.5 (10.3;36.8)	0.0027
RRT, n (%)	37 (9%)	9 (41%)	0.0023	1,58 (0.99–2.46. p = 0.046)
VAP associated, n (%)	39/260 (15%)	8/22 (36%)	0.0136	2.92 (0.98–8.30. P = 0.046)
Mortality, n (%)
In ICU	38 (9%)	8 (36%)	0.0114
In hospital	51 (12%)	9 (41%)	0.0238
LOS, days, median (Q1;Q3)
In ICU	12 (7;21)	21.5 (10.3;31.8)	0.0062
In Hospital	24 (16.8;40)	51 (22.3;69.5)	0.0028

MV mechanical ventilation, CAPA Covid associated pulmonary aspergillosis, RRT renal replacement therapy, VAP ventilated associated pneumonia, LOS length of stay